• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

公众对医疗保健介导的遗传性癌症风险信息披露的支持:瑞典一项基于人群的调查结果。

Public support for healthcare-mediated disclosure of hereditary cancer risk information: Results from a population-based survey in Sweden.

作者信息

Andersson Andreas, Hawranek Carolina, Öfverholm Anna, Ehrencrona Hans, Grill Kalle, Hajdarevic Senada, Melin Beatrice, Tham Emma, Hellquist Barbro Numan, Rosén Anna

机构信息

Department of Radiation Sciences, Umeå University, Umeå, Sweden.

Department of Clinical Sciences, University of Gothenburg, Gothenburg, Sweden.

出版信息

Hered Cancer Clin Pract. 2020 Sep 15;18:18. doi: 10.1186/s13053-020-00151-0. eCollection 2020.

DOI:10.1186/s13053-020-00151-0
PMID:32944097
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7493346/
Abstract

BACKGROUND

Targeted surveillance of at-risk individuals in families with increased risk of hereditary cancer is an effective prevention strategy if relatives are identified, informed and enrolled in screening programs. Despite the potential benefits, many eligible at-risk relatives remain uninformed of their cancer risk. This study describes the general public's opinion on disclosure of hereditary colorectal cancer (CRC) risk information, as well as preferences on the source and the mode of information.

METHODS

A random sample of the general public was assessed through a Swedish citizen web-panel. Respondents were presented with scenarios of being an at-risk relative in a family that had an estimated increased hereditary risk of CRC; either 10% (moderate) or 70% (high) lifetime risk. A colonoscopy was presented as a preventive measure. Results were analysed to identify significant differences between groups using the Pearson's chi-square (χ) test.

RESULTS

Of 1800 invited participants, 977 completed the survey (54%). In the moderate and high-risk scenarios, 89.2 and 90.6% respectively, would like to receive information about a potential hereditary risk of CRC (χ2,  = .755). The desire to be informed was higher among women (91.5%) than men (87.0%, χ2,  = .044). No significant differences were found when comparing different age groups, educational levels, place of residence and having children or not. The preferred source of risk information was a healthcare professional in both moderate and high-risk scenarios (80.1 and 75.5%). However, 18.1 and 20.1% respectively would prefer to be informed by a family member. Assuming that healthcare professionals disclosed the information, the favoured mode of information was letter and phone (38.4 and 33.2%).

CONCLUSIONS

In this study a majority of respondents wanted to be informed about a potential hereditary risk of CRC and preferred healthcare professionals to communicate this information. The two presented levels of CRC lifetime risk did not significantly affect the interest in being informed. Our data offer insights into the needs and preferences of the Swedish population, providing a rationale for developing complementary healthcare-assisted communication pathways to realise the full potential of targeted prevention of hereditary CRC.

摘要

背景

如果能够识别、告知有遗传癌症风险增加的家庭中的高危个体并让其加入筛查项目,那么对这些个体进行针对性监测是一种有效的预防策略。尽管有潜在益处,但许多符合条件的高危亲属仍未被告知其癌症风险。本研究描述了公众对遗传性结直肠癌(CRC)风险信息披露的看法,以及对信息来源和信息传播方式的偏好。

方法

通过瑞典公民网络小组对公众进行随机抽样评估。向受访者呈现这样的情景:他们是一个家庭中的高危亲属,该家庭估计遗传性结直肠癌风险增加;终身风险为10%(中度)或70%(高度)。将结肠镜检查作为一种预防措施。使用Pearson卡方(χ²)检验分析结果,以确定组间的显著差异。

结果

在1800名受邀参与者中,977人完成了调查(54%)。在中度和高度风险情景中,分别有89.2%和90.6%的人希望获得关于遗传性结直肠癌潜在风险的信息(χ² = 0.755)。女性(91.5%)比男性(87.0%,χ² = 0.044)更希望被告知。在比较不同年龄组、教育水平、居住地点以及是否有子女时,未发现显著差异。在中度和高度风险情景中,风险信息的首选来源都是医疗保健专业人员(分别为80.1%和75.5%)。然而,分别有18.1%和20.1%的人更希望由家庭成员告知。假设由医疗保健专业人员披露信息,最受欢迎的信息传播方式是信件和电话(分别为38.4%和33.2%)。

结论

在本研究中,大多数受访者希望被告知遗传性结直肠癌的潜在风险,并更倾向于由医疗保健专业人员传达此信息。所呈现的两个结直肠癌终身风险水平对被告知的意愿没有显著影响。我们的数据为了解瑞典人群的需求和偏好提供了见解,为开发辅助医疗保健的沟通途径以充分发挥遗传性结直肠癌针对性预防的潜力提供了依据。

相似文献

1
Public support for healthcare-mediated disclosure of hereditary cancer risk information: Results from a population-based survey in Sweden.公众对医疗保健介导的遗传性癌症风险信息披露的支持:瑞典一项基于人群的调查结果。
Hered Cancer Clin Pract. 2020 Sep 15;18:18. doi: 10.1186/s13053-020-00151-0. eCollection 2020.
2
Direct letters to relatives at risk of hereditary cancer-study protocol for a multi-center randomized controlled trial of healthcare-assisted versus family-mediated risk disclosure at Swedish cancer genetics clinics (DIRECT-study).直接致信有遗传性癌症风险的亲属 - 瑞典癌症遗传诊所开展医疗辅助与家庭介导风险披露的多中心随机对照试验方案(DIRECT 研究)
Trials. 2023 Dec 17;24(1):810. doi: 10.1186/s13063-023-07829-5.
3
Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.预防性卵巢切除术:降低美国上皮性卵巢癌死亡率。一场持续的争论。
Oncologist. 1996;1(5):326-330.
4
How hereditary cancer risk disclosure to relatives is handled in practice - Patient perspectives from a Swedish cancer genetics clinic.如何在实践中处理遗传性癌症风险向亲属的披露 - 来自瑞典癌症遗传学诊所的患者观点。
Patient Educ Couns. 2024 Sep;126:108319. doi: 10.1016/j.pec.2024.108319. Epub 2024 May 17.
5
The experience of receiving a letter from a cancer genetics clinic about risk for hereditary cancer.收到癌症遗传学诊所关于遗传性癌症风险的信件的体验。
Eur J Hum Genet. 2024 May;32(5):539-544. doi: 10.1038/s41431-024-01551-9. Epub 2024 Feb 14.
6
American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.美国临床肿瘤学会政策声明更新:癌症易感性基因检测
J Clin Oncol. 2003 Jun 15;21(12):2397-406. doi: 10.1200/JCO.2003.03.189. Epub 2003 Apr 11.
7
Attitudes towards disclosure of familial genetic risk in a Mediterranean island population - A survey of the Maltese population.在地中海岛屿人群中对家族遗传风险披露的态度——对马耳他人群的调查。
Eur J Med Genet. 2024 Oct;71:104961. doi: 10.1016/j.ejmg.2024.104961. Epub 2024 Jul 23.
8
High uptake of colonoscopy in first-degree relatives of patients with colorectal cancer in a healthcare region: a population-based, prospective study.在一个医疗保健地区,结直肠癌患者的一级亲属中结肠镜检查的高吸收率:一项基于人群的前瞻性研究。
Endoscopy. 2010 Jan;42(1):15-21. doi: 10.1055/s-0029-1215324. Epub 2010 Jan 11.
9
Positive family history of colorectal cancer in a general practice setting [FRIDA.Frankfurt]: study protocol of a of a cross-sectional study.普通医疗环境中结直肠癌的阳性家族史[弗里达.法兰克福]:一项横断面研究的研究方案
BMC Cancer. 2015 Aug 28;15:605. doi: 10.1186/s12885-015-1600-7.
10
Decentralized colonoscopic surveillance with high patient compliance prevents hereditary and familial colorectal cancer.具有高患者依从性的分散式结肠镜监测可预防遗传性和家族性结直肠癌。
Fam Cancer. 2016 Oct;15(4):543-51. doi: 10.1007/s10689-016-9867-7.

引用本文的文献

1
Genomic findings with familial implications: agenda setting in light of mainstreaming.具有家族性影响的基因组学发现:基于主流化的议程设定
Open Res Eur. 2025 Jan 10;5:4. doi: 10.12688/openreseurope.19128.1. eCollection 2025.
2
Health System-Led Early Consent and Direct Contact of At-Risk Relatives: Pilot Study Results.卫生系统主导的高危亲属早期同意及直接联系:试点研究结果
Public Health Genomics. 2025;28(1):150-162. doi: 10.1159/000545404. Epub 2025 Apr 3.
3
Developing a questionnaire to explore lay people's preferences for communicating hereditary conditions within families: insights from a cognitive interview study.

本文引用的文献

1
How to inform at-risk relatives? Attitudes of 1379 Dutch patients, relatives, and members of the general population.如何告知高危亲属?1379 名荷兰患者、亲属和普通民众的态度。
J Genet Couns. 2020 Oct;29(5):786-799. doi: 10.1002/jgc4.1206. Epub 2019 Dec 30.
2
Benefit from extended surveillance interval on colorectal cancer risk in Lynch syndrome.得益于对林奇综合征患者结直肠癌风险延长监测间隔时间。
Colorectal Dis. 2020 May;22(5):529-536. doi: 10.1111/codi.14926. Epub 2020 Feb 3.
3
Examining intrafamilial communication of colorectal cancer risk status to family members and kin responses to colonoscopy: a qualitative study.
编制一份问卷以探究非专业人士在家庭内部交流遗传疾病方面的偏好:认知访谈研究的见解
J Community Genet. 2025 Mar 18. doi: 10.1007/s12687-025-00783-6.
4
Who has the responsibility to inform relatives at risk of hereditary cancer? A population-based survey in Sweden.谁有责任告知有遗传性癌症风险的亲属?瑞典的一项基于人群的调查。
BMJ Open. 2024 Nov 27;14(11):e089237. doi: 10.1136/bmjopen-2024-089237.
5
Cascade genetic testing in hereditary cancer: exploring the boundaries of the Italian legal framework.遗传性癌症的级联基因检测:探索意大利法律框架的边界。
Fam Cancer. 2024 Nov 20;24(1):9. doi: 10.1007/s10689-024-00430-y.
6
"I Didn't Have to Worry about It": Patient and Family Experiences with Health System Involvement in Notifying Relatives of Genetic Test Results.“我不必为此担心”:患者及其家属对健康系统参与通知亲属遗传检测结果的体验。
Public Health Genomics. 2024;27(1):150-160. doi: 10.1159/000541532. Epub 2024 Sep 30.
7
Exploring family communication preferences in hereditary breast and ovarian cancer and Lynch syndrome: a national Canadian survey.探索遗传性乳腺癌、卵巢癌和林奇综合征患者家庭沟通偏好:一项加拿大全国性调查。
J Community Genet. 2024 Aug;15(4):387-400. doi: 10.1007/s12687-024-00720-z. Epub 2024 Jul 24.
8
National Experiences from 30 Years of Provider-Mediated Cascade Testing in Lynch Syndrome Families-The Danish Model.林奇综合征家族30年提供者介导的级联检测的国家经验——丹麦模式
Cancers (Basel). 2024 Apr 20;16(8):1577. doi: 10.3390/cancers16081577.
9
Clinician perspectives on policy approaches to genetic risk disclosure in families.临床医生对家庭遗传风险披露政策方法的看法。
Fam Cancer. 2024 Jun;23(2):177-186. doi: 10.1007/s10689-024-00375-2. Epub 2024 Mar 28.
10
Direct letters to relatives at risk of hereditary cancer-study protocol for a multi-center randomized controlled trial of healthcare-assisted versus family-mediated risk disclosure at Swedish cancer genetics clinics (DIRECT-study).直接致信有遗传性癌症风险的亲属 - 瑞典癌症遗传诊所开展医疗辅助与家庭介导风险披露的多中心随机对照试验方案(DIRECT 研究)
Trials. 2023 Dec 17;24(1):810. doi: 10.1186/s13063-023-07829-5.
探究结直肠癌风险状况在家族内部向家庭成员的传达以及亲属对结肠镜检查的反应:一项定性研究。
Hered Cancer Clin Pract. 2019 Jun 26;17:16. doi: 10.1186/s13053-019-0114-8. eCollection 2019.
4
How to inform relatives at risk of hereditary diseases? A mixed-methods systematic review on patient attitudes.如何告知有遗传疾病风险的亲属?一项关于患者态度的混合方法系统评价
J Genet Couns. 2019 Oct;28(5):1042-1058. doi: 10.1002/jgc4.1143. Epub 2019 Jun 19.
5
Evaluation of the template letter regarding the disclosure of genetic information within the family in France.法国关于家庭内部遗传信息披露的模板信函评估。
J Community Genet. 2019 Oct;10(4):489-499. doi: 10.1007/s12687-019-00418-7. Epub 2019 Mar 27.
6
The uptake of presymptomatic genetic testing in hereditary breast-ovarian cancer and Lynch syndrome: a systematic review of the literature and implications for clinical practice.遗传性乳腺癌-卵巢癌和林奇综合征的症状前基因检测应用:文献系统综述及对临床实践的启示
Fam Cancer. 2019 Jan;18(1):127-135. doi: 10.1007/s10689-018-0089-z.
7
Patient and provider perspectives on adherence to and care coordination of lynch syndrome surveillance recommendations: findings from qualitative interviews.患者及医疗服务提供者对林奇综合征监测建议的依从性和护理协调的看法:定性访谈结果
Hered Cancer Clin Pract. 2018 May 10;16:11. doi: 10.1186/s13053-018-0090-4. eCollection 2018.
8
Unsolicited information letters to increase awareness of Lynch syndrome and familial colorectal cancer: reactions and attitudes.用于提高林奇综合征和家族性结直肠癌认知度的主动提供信息信件:反应与态度
Fam Cancer. 2019 Jan;18(1):43-51. doi: 10.1007/s10689-018-0083-5.
9
Genetic diseases and information to relatives: practical and ethical issues for professionals after introduction of a legal framework in France.遗传性疾病及其相关信息向亲属告知:法国引入法律框架后的专业人员所面临的实际问题与伦理问题。
Eur J Hum Genet. 2018 Jun;26(6):786-795. doi: 10.1038/s41431-018-0103-9. Epub 2018 Feb 27.
10
Which Lynch syndrome screening programs could be implemented in the "real world"? A systematic review of economic evaluations.哪些林奇综合征筛查方案可以在“现实世界”中实施?一项经济评估的系统综述。
Genet Med. 2018 Oct;20(10):1131-1144. doi: 10.1038/gim.2017.244. Epub 2018 Jan 4.